Highly active antiretroviral therapy in HIV-associated pulmonary hypertension
Barbaro, G.; Lucchini, A.; Barbarini, G.
Minerva Cardioangiologica 53(2): 153-154
2005
ISSN/ISBN: 0026-4725 PMID: 15986010 Document Number: 585595
Document emailed within 1 workday
Related Documents
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Bwana, V.; Tenu, F.; Magesa, S.M.; Mfinanga, S.G. 2011: Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania Tanzania Journal of Health Research 13(1): 14-20
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Chen, L.F.; Hoy, J.; Lewin, S.R. 2007: Ten years of highly active antiretroviral therapy for HIV infection Medical journal of Australia 186(3): 146-151
Gates, A.E.; Kaplan, L.D. 2002: AIDS malignancies in the era of highly active antiretroviral therapy Oncology 16(5): 657-665; Discussion 665: 668-670
Edlin, B.R. 1999: Change of HAART. Highly active antiretroviral therapy Lancet 353(9167): 1888
Chu, J.H.; Gange, S.J.; Anastos, K.; Minkoff, H.; Cejtin, H.; Bacon, M.; Levine, A.; Greenblatt, R.M. 2005: Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy American Journal of Epidemiology 161(9): 881-890
Parakh, A.; Dubey, A.P.; Kumar, A.; Maheshwari, A. 2009: Lipodystrophy and metabolic complications of highly active antiretroviral therapy Indian Journal of Pediatrics 76(10): 1017-1021
Idiculla, J. 2011: Anthropometric changes in patients receiving highly active antiretroviral therapy (ART) Journal of the Association of Physicians of India 59: 530; Author Reply 530
Pearson, C.R.; Micek, M.; Simoni, J.M.; Matediana, E.; Martin, D.P.; Gloyd, S. 2006: Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation Journal of Acquired Immune Deficiency Syndromes 43(Suppl 1): S134-S141
Harvey, K.M.; Carrington, D.; Duncan, J.; Figueroa, J.P.; Hirschorn, L.; Manning, D.; Jackson, S. 2008: Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica West Indian Medical Journal 57(3): 293-297
Egger, M.; Junghans, C.; Friis Moller, N.; Lundgren, J.D. 2001: Highly active antiretroviral therapy and coronary heart disease: the need for perspective AIDS 15(Suppl 5): S193-S201
Nelwan, E.J. 2014: Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient Acta Medica Indonesiana 46(4): 273-274
Ezeanolue, E.E.; Stumpf, P.G.; Soliman, E.; Fernandez, G.; Jack, I. 2011: Contraception choices in a cohort of HIV+ women in the era of highly active antiretroviral therapy Contraception 84(1): 94-97
Deng, X.-j.; He, Y.; Yang, L.; Zou, S.-p.; Yang, H.; Zheng, Y.-h. 2011: The evaluation of four-year highly active antiretroviral therapy in HIV-1 infected patients Zhonghua Nei Ke Za Zhi 50(3): 230-234
Loubiere, S.; el Filal, K.M.; Sodqi, M.; Loundou, A.; Luchini, S.ép.; Cleary, S.; Moatti, J.-P.; Himmich, H. 2008: When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience Antiviral Therapy 13(2): 241-251
Manfredi, R.; Calza, L. 2009: Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy Recenti Progressi in Medicina 100(12): 547-549
Duran, A.C.F.L.; Almeida, L.B.; Segurado, A.A.C.; Jaime, P.C. 2008: Diet quality of persons living with HIV/AIDS on highly active antiretroviral therapy Journal of Human Nutrition and Dietetics: the Official Journal of the British Dietetic Association 21(4): 346-350